Loading...
Keywords
Last Name
Institution
Back to Search Results

Connection

Search Results to Erin M. Guest

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Guest, Erin

PropertyValue
research overview Dr. Guest's research areas of focus are in leukemia in infants, cancer genomics, and cancer predisposition syndromes. She is the study chair for the National Cancer Institute sponsored Children's Oncology Group clinical trial for infants with acute lymphoblastic leukemia (ALL) and she leads the national task force on infant ALL. Dr. Guest collaborates with researchers around the world to discover and develop new, more effective therapies for infants with leukemia.

One or more keywords matched the following items that are connected to Guest, Erin

Item TypeName
Concept Breast Neoplasms
Concept Neoplasm Recurrence, Local
Concept Neoplasms
Concept Neoplasms, Muscle Tissue
Concept RNA, Neoplasm
Concept Tongue Neoplasms
Concept Tumor Cells, Cultured
Concept Biomarkers, Tumor
Concept Neoplasm, Residual
Concept Drug Resistance, Neoplasm
Academic Article Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.
Academic Article The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output.
Academic Article Childhood cancer for the primary care physician.
Academic Article Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Academic Article Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects.
Grant Identifying biomarkers of relapse in infant acute lymphoblastic leukemia (ALL) through single cell sequencing
Grant Overcoming therapeutic resistance by repurposing a classic chemotherapeutic drug as targeted therapy to reactivate anti-cancer immunity
Academic Article Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma.
Academic Article Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib.
Academic Article Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study.
Academic Article Overcoming Wnt-?-catenin dependent anticancer therapy resistance in leukaemia stem cells.
Grant A multi-omics approach to overcome resistance in infant leukemia by identifying immune-therapy failure mechanisms
Academic Article Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy.
Grant Free the Data: Open Sharing of Comprehensive Genomic Childhood Cancer Datasets
Academic Article Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.
Grant Centromeric DNA instability as a biomarker in Acute Lymphoblastic Leukemia
Grant Evaluating the Impact of Rare, Clinically Detected Germline Variants in MLL-AF4 Leukemia: A Bedside-to-Bench Translational Model of Infant ALL
Academic Article The nature and importance of women's goals for immediate and delayed breast reconstruction.
Academic Article Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-M?nster Study Group.
Academic Article Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Grant Venetoclax for infant ALL – COG AALL2321

Search Criteria
  • Neoplasms